Datavant · 3 hours ago
Software Engineer
Datavant is a data platform company and the world’s leader in health data exchange. As a Software Engineer III, you will own end-to-end delivery for projects, translating requirements into scalable systems and mentoring junior engineers.
BiopharmaClinical TrialsData IntegrationHealth CareSoftware
Responsibilities
Lead design and development of complex backend or full-stack features
Collaborate cross-functionally to define scope, requirements, and timelines
Implement solutions that emphasize reliability, scale, security, and performance
Contribute to improving CI/CD pipelines, testing frameworks, and developer tooling
Mentor junior engineers, such as through design reviews and pair programming
Qualification
Required
3-6 years of software engineering experience, ideally within enterprise SaaS or healthcare tech
Strong technical depth in distributed systems and API design/development
Experience with infrastructure-as-code and observability tools (DataDog, CloudWatch)
Proficiency in AWS architecture, CI/CD pipelines, and modern frameworks
Ability to balance execution and architectural foresight
Model accountability and ownership in team projects
Encourage collaboration and technical learning across peers
Maintain curiosity for both technical and business context
Communicate effectively across engineering and product
Demonstrate resilience and adaptability in problem-solving
Earn trust through reliable delivery and proactive risk communication
Obsess over customers by shaping requirements and ensuring system excellence
Prioritize growth over comfort through ongoing architectural development
Win as a team by mentoring, aligning stakeholders, and enabling others
Rise to the challenge by solving complex problems with speed and rigor
Company
Datavant
Datavant protects, connects, and delivers the world’s health data to power better decisions and advance human health.
Funding
Current Stage
Late StageTotal Funding
$80.5MKey Investors
Transformation Capital
2020-10-08Series B· $40M
2018-04-30Series Unknown· $40.5M
Recent News
2026-01-19
2025-12-31
Company data provided by crunchbase